Remove 2015 Remove Competition Remove Pharma Remove Physicians
article thumbnail

Comparison of Humira biosimilars in the US and Europe

Pharmaceutical Technology

Biosimilars are an important tool to facilitate competition, lower the price of drugs, and create savings across the board. Until 2010, no regulatory approval pathway for biosimilars existed in the US and the first biosimilar was only approved in the US in 2015. For example, AbbVie had obtained more than 100 patents for Humira.

article thumbnail

5 Core Tenets of HCP-focused Point-of-Care Marketing

PM360

The EHR is the Holy Grail of POC Messaging (At Least for Now) Reaching HCPs while they’re prescribing is the epitome of physician messaging. The Medical Literature Reports on POC Too; They Call it “Nudging” It’s not just pharma that’s interested in changing prescriber behavior.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The evolving role of social media in healthcare

pharmaphorum

In recent years, social media has evolved into an essential part of pharma operations, for better or worse. Below, I’m exploring a few ways that pharma teams are using social media and other online collaboration platforms to connect, educate, and influence. Healthcare Provider (HCP) marketing. Congress Coverage.

Media 84
article thumbnail

U.S. market access landscape: A push for control is erasing the boundary between payers and providers in U.S. healthcare

Clarivate

CVS then began affiliating with health systems across the country (like Cleveland Clinic ) for physician oversight of MinuteClinic’s staffed midlevel providers, just as Walgreens was rising as a formidable competitor in the convenient care space through its own walk-in clinics that it launched in fall 2006. Key acquisitions by U.S.

article thumbnail

The Evolving Role of Social Media in Healthcare

Impetus Digital

A couple of years ago, I first wrote about how social media’s role in the Pharma and healthcare sectors has been growing exponentially. In recent years, social media has evolved into an essential part of Pharma operations, for better or worse. . Pharma companies have to be careful when considering their involvement.

Media 52
article thumbnail

Fixed-dose combination: Considerations for design, formulation, manufacturing and analysis

Pharmaceutical Technology

Understanding both the significant competitive advantages that FDC products can offer, and the difficulties and potential pitfalls associated with development and manufacturing of FDC drugs in oral solid dosage forms is a critical first step for companies exploring this approach. More FDC products flowing into pharma pipelines.